Hironori Ueda

I had been studying the genetic backgrounds and the etiology of Diabetes Mellitus in Osaka University in Japan, University of Cambridge in England and Stanford University in California. After moving on to Health Care Center, Kwansei‐Gakuin University, I am interested in caring for and treating patients with Diabetes Mellitus, specially utilizing Imeglimin, new insulins, glucagon-like peptide 1 analogues and sodium glucose cotransporter 2 inhibitors.